Previous Page  2 / 53 Next Page
Information
Show Menu
Previous Page 2 / 53 Next Page
Page Background

Medchem & Toxicology 2018

Page 33

Journal of Organic & Inorganic Chemistry

ISSN: 2472-1123

A n n u a l C o n g r e s s o n

Medicinal Chemistry,

Pharmacology and toxicology

J u l y 3 0 - 3 1 , 2 0 1 8

Am s t e r d a m , N e t h e r l a n d s

R

ecently we described a novel class of imidazopyridine compounds

that showed exceptional anti-RSV potency in cell culture. However,

unfavorable pharmacokinetic (PK) properties and glutathione (GSH)

adduct liabilities impeded their further development. In a bid to

address the PK and early safety concerns, a small compound library

consisting of dozens of scaffold-hopping analogues was designed

and synthesized for RSV CPE assay screening, which led to the

identification of a new chemical starting point: methylsulfonyl indole

compound 8. In this poster, we present the discovery and optimization

of a series of methylsulfonyl indazoles as potent RSV fusion inhibitors.

In particular, compound 47 was orally efficacious in a RSV mouse

model, with 1.6 log unit viral load reduction at 25 mg/kg BID upon oral

dosing. The results may have broad implications for the design of new

RSV fusion inhibitors, and demonstrate the potential for developing

novel therapies for RSV infection.

Image

Discovery of methylsulfonyl indazoles as potent and orally

active respiratory syncytial virus (RSV) fusion inhibitors

Song Feng

1

, Chao Li

2

, Dongdong Chen

1

, Xiufang Zheng

1

, Hongying

Yun

1

, Lu Gao

1

and Hong C Shen

1

1

Roche Innovation Center, Shanghai, China

2

Ascentage Pharma, Suzhou, Jiangsu, China

Biography

Song Feng has obtained his PhD in 2004 fromShanghai Institue of Materia

Medica(SIMM), Chinese Academy of Sciences(ACS), and completed his

Postdoctoral studies in Arizonal Statie University andOhio State Univerisity

from 2004 to 2006. Now he is a Principal Scientist in Roche Inovation

Center Shagnhai (RICS). He has published more than 25 papers in reputed

journals and more than 10 patents in Cardiovascular and Metabolism

(CVM) and infectious disease research area.

andrew.feng@roche.om

Song Feng et al., J Org Inorg Chem 2018, Volume 4

DOI: 10.21767/2472-1123-C3-009